Document Detail


The use of quinolones in respiratory tract infections.
MedLine Citation:
PMID:  3325259     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a prospective (and continuing) trial, a total of 271 patients with acute purulent exacerbations of chronic respiratory disease (bacteriologically confirmed) were treated with various new oral quinolones including enoxacin (26), pefloxacin (50), ciprofloxacin (80) and ofloxacin (115). Various therapeutic schedules were employed, with differing drug dosages, frequencies of administration and durations of treatment. All patients were investigated microbiologically during and immediately after treatment and after 7 days of follow-up. The best clinical results were noted after ofloxacin 800 mg once daily for 7 days, which showed excellent gastrointestinal absorption and rapid penetration through to the sputum. Some of the treatment failures with enoxacin and pefloxacin could be ascribed to the development of resistance during treatment, rises in minimal inhibitory concentrations (MICs) being noted with Streptococcus pneumoniae and Pseudomonas aeruginosa.
Authors:
F P Maesen; B I Davies; W H Geraedts; C Baur
Related Documents :
18680179 - Good effect of igy against pseudomonas aeruginosa infections in cystic fibrosis patients.
9105549 - Cefodizime given in single or divided doses for the treatment of lower respiratory trac...
9647029 - The effect of ciprofloxacin in the prevention of bacterial infection in patients with c...
8284649 - Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acu...
1498569 - The safety and efficacy of topical norfloxacin compared with placebo in the treatment o...
20346539 - Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abs...
12490799 - Narrowband uv-b phototherapy in the treatment of cutaneous graft versus host disease.
17360989 - A comparison of allografting with autografting for newly diagnosed myeloma.
19683689 - Abdominal sacrocolpopexy and urinary incontinence: surgical planning based on urodynamics.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Drugs     Volume:  34 Suppl 1     ISSN:  0012-6667     ISO Abbreviation:  Drugs     Publication Date:  1987  
Date Detail:
Created Date:  1988-03-30     Completed Date:  1988-03-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7600076     Medline TA:  Drugs     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  74-9     Citation Subset:  IM    
Affiliation:
Department of Respiratory Diseases, De Wever Ziekenhuis, Heerlen.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / adverse effects,  pharmacokinetics,  therapeutic use*
Bronchitis / complications
Chronic Disease
Clinical Trials as Topic
Humans
Microbial Sensitivity Tests
Ofloxacin
Oxazines / adverse effects,  pharmacokinetics,  therapeutic use*
Quinolines / therapeutic use*
Respiratory Tract Infections / drug therapy*,  etiology,  microbiology
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 0/Oxazines; 0/Quinolines; 82419-36-1/Ofloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overview of toxicological studies.
Next Document:  Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study.